|
09 Mar 2021 |
Lilly and Biolojic Design Announce Research Collaboration to Discover and Develop Antibody Therapies for Diabetes
|
|
05 Mar 2021 |
ALX Oncology and Tallac Therapeutics Announce Collaboration on Novel Class of Cancer Immunotherapeutics
|
|
04 Mar 2021 |
Amunix Raises $117 Million Series B Financing to Fund its Oncology Pipeline
|
|
02 Mar 2021 |
Mitokinin, Inc., Enters into Purchase Right Agreement with AbbVie
|
|
02 Mar 2021 |
Fusion Pharmaceuticals to Expand Pipeline with Acquisition of IPN-1087, a Small Molecule Targeting NTSR1, from Ipsen
|
|
01 Mar 2021 |
Phio Pharmaceuticals and AgonOx, Inc. Announce Collaboration on Clinical Development of Novel T Cell-based Cancer Immunotherapies
|
|
01 Mar 2021 |
Boehringer Ingelheim and Gubra Join Forces to Identify and Validate Innovative Peptides for the Treatment of Obesity
|
|
01 Mar 2021 |
HitGen and UPPTHERA Enter Into Drug Discovery Research Collaboration
|
|
25 Feb 2021 |
Merck to Acquire Pandion Therapeutics
|
|
24 Feb 2021 |
SIRION Biotech Announces Collaboration with Sanofi to Innovate Gene Therapy Treatments with Improved Adeno-Associated Virus Capsids
|
|
22 Feb 2021 |
Arcturus Therapeutics Acquires Exclusive License to mRNA Manufacturing Technology from Alexion Pharmaceuticals
|
|
17 Feb 2021 |
GSK and Vir Biotechnology Expand Coronavirus Collaboration to Advance New Therapeutics for Influenza and Other Respiratory Viruses
|
|
17 Feb 2021 |
Novartis and the Bill & Melinda Gates Foundation collaborate to discover and develop an accessible in vivo gene therapy for sickle cell disease
|
|
17 Feb 2021 |
Almirall and MC2 Therapeutics enter a license, collaboration and commercialization agreement for European rights to Wynzora® Cream for treatment of plaque psoriasis
|
|
16 Feb 2021 |
Cytovia Therapeutics and Cellectis Partner to Develop TALEN® Gene-Edited iPSC-Derived Natural Killer Cells
|
|
16 Feb 2021 |
Sensorion Announces Third Gene Therapy Collaboration With Institut Pasteur Targeting Important Pediatric and Adult Deafness Segments
|
|
16 Feb 2021 |
Onward Therapeutics and Biomunex Pharmaceuticals Enter into a Worldwide Exclusive License and Co-development Agreement to a Bispecific Antibody for Immuno-Oncology
|
|
09 Feb 2021 |
Heat Biologics Announces Positive Interim Survival Data from Ongoing HS-110 Phase 2 Non-Small Cell Lung Cancer Trial
|
|
05 Feb 2021 |
Imcyse Enters into Research Collaboration and License Agreement for its Imotope™ Technology with Pfizer in Rheumatoid Arthritis
|
|
03 Feb 2021 |
Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma Leader
|
|
02 Feb 2021 |
X-Chem Enters into Multitarget Oncology Discovery Research Collaboration and License Agreement with Genentech
|
|
02 Feb 2021 |
Ribon Therapeutics Announces License Agreement with Ono Pharmaceutical Co., Ltd. to Develop and Commercialize RBN-2397 In Japan, South Korea, Taiwan and ASEAN Countries
|
|
01 Feb 2021 |
Gilead Sciences and Gritstone Announce Collaboration Utilizing Gritstone’s Vaccine Platform Technology for HIV Cure
|
|
01 Feb 2021 |
Horizon Therapeutics plc to Acquire Viela Bio, Inc. to Significantly Expand Development Pipeline and Grow Rare Disease Medicine Portfolio
|
|
25 Jan 2021 |
Evozyne and Takeda Announce Strategic Collaboration and License Agreement
|
